6568 KNC Laboratories Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6568

TSE Growth

KNC Laboratories Co., Ltd.

1,112

JPY

-2

(-0.18%)

Dec 5, 1:06 pm JST

7.16

USD

Dec 4, 11:06 pm EST

Result

PTS

outside of trading hours

1,117

Dec 5, 9:25 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	7,440	1,094	1,102	643	82.8	25	May 13, 2022	J-GAAP
Mar, 2023	8,628	2,163	2,199	1,542	200.1	28	May 12, 2023	J-GAAP
Mar, 2024	9,154	2,081	2,094	1,493	193.5	30	May 13, 2024	J-GAAP
Mar, 2025	8,178	771	929	737	95.4	33	May 13, 2025	J-GAAP
Mar, 2026 Guidance	8,600	780	800	584	75.4	33	May 13, 2025	J-GAAP
YoY	+5.2%	+1.2%	-13.9%	-20.8%	-20.9%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 13, 2020	6,800	950	1,000	740	25	J-GAAP
	Feb 12, 2021	5,850	530	570	310	25	J-GAAP
Results	May 13, 2021	6,029	635	677	399	25	J-GAAP
Mar, 2022	May 13, 2021	Available in future release
	Apr 15, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	Feb 10, 2023
	Apr 21, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
Results	May 13, 2024
Mar, 2025	May 13, 2024
	Feb 14, 2025
Results	May 13, 2025
Mar, 2026	May 13, 2025	8,600	780	800	584	33	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2013	3,805	－	Available in future release
Mar, 2014	4,004	+5.2
Mar, 2015	3,811	-4.8
Mar, 2016	4,612	+21.0
Mar, 2017	4,768	+3.4
Mar, 2018	6,312	+32.4
Mar, 2019	6,290	-0.3
Mar, 2020	6,347	+0.9
Mar, 2021	6,029	-5.0
Mar, 2022	7,440	+23.4
Mar, 2023	8,628	+16.0
Mar, 2024	9,154	+6.1
Mar, 2025	8,178	-10.7
Mar, 2026 Guidance	8,600	+5.2	780	+1.2	800	-13.9	75.4	-21.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	9,154	2,081	22.7	12.03	8.78	0.54	193.5
Mar, 2025	8,178	771	9.43	5.54	3.80	0.42	95.4
Mar, 2026 Guidance	8,600	780	9.07	4.35	2.85	0.42	75.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	9,154	2,163	2,199	1,542	484,329
Fiscal Year	Mar, 2024	Mar, 2023	Mar, 2023	Mar, 2023	Mar, 2017

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	5,902	1,742	1,755	1,235	160.2	18	May 12, 2023	J-GAAP
Oct - Mar, 2023	5,782	1,453	1,459	1,053	136.5	15	May 13, 2024	J-GAAP
Oct - Mar, 2024	4,856	695	843	683	88.4	17	May 13, 2025	J-GAAP
Oct - Mar, 2025 Guidance	5,226	780	789	583	75.3	17	Nov 14, 2025	J-GAAP
YoY	+7.6%	+12.2%	-6.4%	-14.6%	-14.8%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	2,163	847	1,993	-1,146	-523	2,297	14.91	J-GAAP
Mar, 2024	2,081	835	3,204	-2,369	178	3,311	17.78	J-GAAP
Mar, 2025	771	-1,835	1,487	-3,322	909	2,385	11.84	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	3,372	628	635	440	57.2	30.3	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	3,322	76	86	54	7.1	9.3	Nov 8, 2024	J-GAAP
Apr - Sep, 2025	3,374	0	11	1	0.1	1.4	Nov 14, 2025	J-GAAP
YoY	+1.6%	－	-87.2%	-98.1%	-98.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	1,812	222	229	155	20.1	12.3	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	3,970	1,231	1,230	898	116.4	31.0	May 13, 2024	J-GAAP
Apr - Jun, 2024	1,405	85	87	56	7.3	6.0	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	1,917	-9	-1	-2	-0.3	-0.5	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	1,932	246	398	284	36.8	12.7	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	2,924	449	445	399	51.7	15.4	May 13, 2025	J-GAAP
Apr - Jun, 2025	1,694	-9	-11	-11	-1.5	-0.5	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	1,680	9	22	12	1.6	0.5	Nov 14, 2025	J-GAAP
YoY	-12.4%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	1,325	-15.4	Available in future release
Jan - Mar, 2021	2,114	-8.8
Apr - Jun, 2021	975	-8.4
Jul - Sep, 2021	1,867	+22.3
Oct - Dec, 2021	1,557	+17.5
Jan - Mar, 2022	3,041	+43.9
Apr - Jun, 2022	1,222	+25.3
Jul - Sep, 2022	1,504	-19.4
Oct - Dec, 2022	2,037	+30.8
Jan - Mar, 2023	3,865	+27.1
Apr - Jun, 2023	1,779	+45.6
Jul - Sep, 2023	1,593	+5.9
Oct - Dec, 2023	1,812	-11.0
Jan - Mar, 2024	3,970	+2.7
Apr - Jun, 2024	1,405	-21.0
Jul - Sep, 2024	1,917	+20.3
Oct - Dec, 2024	1,932	+6.6
Jan - Mar, 2025	2,924	-26.3
Apr - Jun, 2025	1,694	+20.6
Jul - Sep, 2025	1,680	-12.4	9	－	22	－	1.6	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,970	1,283	1,288	914	118.6
Fiscal Year	Mar, 2024	Mar, 2023	Mar, 2023	Mar, 2023	Mar, 2023

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	1,523.41	76.2	15,404	11,745	7,830	0.13	May 12, 2023	J-GAAP
Mar, 2024	1,695.35	70.3	18,621	13,086	9,068	0.15	May 13, 2024	J-GAAP
Mar, 2025	1,748.68	67.1	20,152	13,520	9,566	0.23	May 13, 2025	J-GAAP
Apr - Sep, 2025	ー	65.4	20,497	13,414	9,436	0.24	Nov 14, 2025	J-GAAP

KNC Laboratories Co., Ltd.(6568) Financial Results